Drug Database
Back to search

Poland· PL-100455323

Adtralza

A tralokinumab product containing tralokinumabum, registered in Poland by LEO Pharma A/S. The same ATC class is registered in 14 of our 19 countries.

ATC D11AH07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAdtralzaATCD11AH07REGISTER NO.PL-100455323PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tralokinumabumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tralokinumab is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AH07 (tralokinumab), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search tralokinumab products by name

Tralokinumab · ATC D11AH07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tralokinumab costs, country by country.

Normalised to the WHO defined daily dose (16.1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tralokinumab · price per daily dose (16.1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$34.49
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Tralokinumabum
Manufacturer
LEO Pharma A/S
Country
Poland (PL)
ATC code
D11AH07
ATC class
Tralokinumab
Defined daily dose
16.1 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    03400930230268

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tralokinumab in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tralokinumab products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Adtralza
  • Iceland · Adtralza
  • Liechtenstein · Adtralza
  • Norway · Adtralza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/72bf05d5-a03e-4175-b4f7-77dc1dac8f69
GET /v1/drugs/72bf05d5-a03e-4175-b4f7-77dc1dac8f69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
  "source": "urpl",
  "strength": "150 mg",
  "packaging": "03400930230268 ¦ Rpz ¦ EU/1/21/1554/002 ¦ 141077\n4 amp.-strzyk. 1 ml (op. zbiorcze)\n¦ UR/Z/4c/041/24 - 03400930230268 ¦ UR/Z/4c/150/22 - 03400930230268 ¦ UR/Z/4c/137/23 - 03400930230268 ¦ UR/Z/4c/156/23 - 03400930230268 ¦ UR/Z/4c/072/24 - 03400930230268\nRpz ¦ EU/1/21/1554/001 ¦ 141078\n2 amp.-strzyk. 1 ml\nRpz ¦ EU/1/21/1554/003 ¦ 141079\n12 amp.-strzyk. 1 ml (op. zbiorcze)",
  "substance": "Tralokinumabum 150 mg",
  "common_name": "Tralokinumabum",
  "pl_product_id": "100455323",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about tralokinumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console